Literature DB >> 28256060

Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.

S Singh1, S K Verma1, S Kumar1, M K Ahmad2, A Nischal3, S K Singh4, R K Dixit3.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a common respiratory condition involving the airways and characterized by airflow limitation. Gaseous and noxious particles play an important role in this process. Antioxidants are the substances that may protect cells from the damage caused by unstable molecules known as free radicals. The increased oxidative stress in patients with COPD is the result of an increased burden of inhaled oxidants, as well as increased amounts of reactive oxygen species (ROS) generated by various inflammatory, immune and epithelial cells of the airways. A total of 150 subjects with COPD and 100 healthy controls subjects were enrolled in this study from the period October 2015 to January 2016. The investigation included measurements of plasma superoxide dismutase activity (SOD), catalase activity (CAT), glutathione content (GSH) reduced form, (GPx) glutathione peroxidase, glutathione reductase (GR) and lipid peroxidation (LPO). Absorbance was measured by UV spectrophotometer. The estimated values of SOD, catalase, GPx, GSH and GR were found to be significantly (P = 0.0001) lower among the cases compared with controls. But, the levels of MDA were higher (P = 0.0001) in cases as compared to control group and there was significant difference in the oxidative stress parameters among the various stages of COPD. The post hoc analysis revealed that SOD was significantly (P < 0.01) lower among the mild, moderate and severe patients compared with very severe patients. The catalase was also observed to be significantly (P = 0.01) lower among mild, moderate and severe patients than very severe patients. The GPx was found to be significantly (P = 0.002) lower among the mild, moderate and severe patients compared with very severe patients. MDA was observed to be significantly higher in mild, moderate and severe patients compared with very severe (P = 0.001). GR was significantly (P = 0.003) lower among mild, moderate and severe patients than very severe patients. However, there was no significant difference in GSH among severity of COPD patients. This study suggests that oxidant and antioxidant imbalance plays an important role in various stages of severity of COPD. These results revealed the presence of an oxidative stress in subjects with COPD, and it is proportionate to the severity of disease.
© 2016 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28256060     DOI: 10.1111/sji.12498

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  12 in total

1.  Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients.

Authors:  Walter H Watson; Jeffrey D Ritzenthaler; Paula Peyrani; Timothy L Wiemken; Stephen Furmanek; Andrea M Reyes Vega; Tom J Burke; Yuxuan Zheng; Julio A Ramirez; Jesse Roman
Journal:  Free Radic Biol Med       Date:  2019-07-29       Impact factor: 7.376

2.  Profiling of cell stress proteins reveals decreased expression of enzymatic antioxidants in tracheal epithelial tissue of pigs raised indoors.

Authors:  Jenora T Waterman; Chakia J McClendon; Rohit S Ranabhat; KeYona T Barton
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  Association of serum bilirubin level with lung function decline: a Korean community-based cohort study.

Authors:  Ah Young Leem; Ha Yan Kim; Young Sam Kim; Moo Suk Park; Joon Chang; Ji Ye Jung
Journal:  Respir Res       Date:  2018-05-23

Review 4.  Reliability and Usefulness of Different Biomarkers of Oxidative Stress in Chronic Obstructive Pulmonary Disease.

Authors:  Elisabetta Zinellu; Angelo Zinellu; Alessandro G Fois; Sara S Fois; Barbara Piras; Ciriaco Carru; Pietro Pirina
Journal:  Oxid Med Cell Longev       Date:  2020-05-14       Impact factor: 6.543

5.  Protective Effect of Jianpiyifei II Granule against Chronic Obstructive Pulmonary Disease via NF-κB Signaling Pathway.

Authors:  Long Fan; Ruifeng Chen; Leng Li; Ziyao Liang; Xuhua Yu; Kai Huang; Shuomiao Yin; Lei Wu; Yuanbin Chen; Yinji Xu; Qi Wang; Lin Lin
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-05       Impact factor: 2.629

6.  The Significance of Serum Interleukin-8 in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Jingxi Zhang; Chong Bai
Journal:  Tanaffos       Date:  2018-01

7.  The Impacts of Ramadan Intermittent Fasting on Oxidant/Antioxidant Stress Biomarkers of Stable Chronic Obstructive Pulmonary Disease Male Patients.

Authors:  Sawssan Mrad; Hadhemi Rejeb; Jihene Ben Abdallah; Hajer Graiet; Mouna Ben Khelifa; Amel Abed; Salima Ferchichi; Khelifa Limem; Helmi Ben Saad
Journal:  Am J Mens Health       Date:  2019 May-Jun

Review 8.  Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology.

Authors:  Zhen Chen; Pan Chen; Hao Wu; Rui Shi; Weiwei Su; Yonggang Wang; Peibo Li
Journal:  Biomolecules       Date:  2020-12-08

9.  Expression of nuclear factor erythroid-2-related factor 2, broad complex-tramtrack-bric a brac and Cap'n'collar homology 1 and γ-glutamic acid cysteine synthase in peripheral blood of patients with chronic obstructive pulmonary disease and its clinical significance.

Authors:  Dongrong Li; Ding Sun; Yehan Zhu
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

10.  Total Antioxidant Status in Stable Chronic Obstructive Pulmonary Disease.

Authors:  Marina Hlavati; Svetlana Tomić; Krunoslav Buljan; Vikica Buljanović; Ivan Feldi; Silva Butković-Soldo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.